← Leaderboards
Anna R Migliaccio
New York Blood Center
$7,273,775
Attributed
$8,121,275
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $987.1K · FY2011–22$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$8,121,275 · 5
By mechanism
P01$4,529,982 · 2
R01$3,354,828 · 2
P50$236,465 · 1
Top collaborators
- James J Bieker4 shared
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadCellsInflammatoryGene ExpressionIn VivoGeneticRegulationBiologyOverexpressionMutationNeutrophilMyelofibrosisAnimal ModelPatternJak2 GeneDisease ProgressionLoss Of FunctionGrowth FactorDefectHematopoiesisBone MarrowHematopoieticAffectMegakaryocytes
Grant awards (19)
Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis$535,067
P01 · FY2022 · CA · contact PI
Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis$545,986
P01 · FY2021 · CA · contact PI
Generation of cultured RBCs with rare phenotypes for transfusion from sources usually discarded during regular blood donations$423,750
R01 · FY2021 · HL
Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis$545,986
P01 · FY2020 · CA · contact PI
Generation of cultured RBCs with rare phenotypes for transfusion from sources usually discarded during regular blood donations$423,750
R01 · FY2020 · HL
Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis$529,608
P01 · FY2019 · CA · contact PI
Generation of cultured RBCs with rare phenotypes for transfusion from sources usually discarded during regular blood donations$423,750
R01 · FY2019 · HL
Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis$563,362
P01 · FY2018 · CA · contact PI
Generation of cultured RBCs with rare phenotypes for transfusion from sources usually discarded during regular blood donations$423,750
R01 · FY2018 · HL
Mouse Models of Myelofibrosis$475,237
P01 · FY2015 · CA · contact PI
The human glucocorticoid receptor and normal and pathological terminal erythroid$417,393
R01 · FY2015 · HL · contact PI
The human glucocorticoid receptor and normal and pathological terminal erythroid$415,275
R01 · FY2014 · HL · contact PI
Mouse Models of Myelofibrosis$299,320
P01 · FY2014 · CA · contact PI
The human glucocorticoid receptor and normal and pathological terminal erythroid$403,410
R01 · FY2013 · HL · contact PI
Mouse Models of Myelofibrosis$327,081
P01 · FY2013 · CA · contact PI
The human glucocorticoid receptor and normal and pathological terminal erythroid$423,750
R01 · FY2012 · HL · contact PI
Mouse Models of Myelofibrosis$369,749
P01 · FY2012 · CA · contact PI
Mouse Models of Myelofibrosis$338,586
P01 · FY2011 · CA · contact PI
CORE--TISSUE CULTURE$236,465
P50 · FY2000 · HL